Skip to main content
SpringerLink
Log in

Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Russell SJ, El-Khatib FH, Sinha M, Magyar KL, McKeon K, Damiano ER et al (2014) Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 371:313–325. doi:10.1056/NEJMoa1314474

    Article  PubMed Central  PubMed  Google Scholar 

  2. Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Doyle FJ 3rd et al (2014) Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 37:1789–1796. doi:10.2337/dc13-2076

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329:977–986

    Article  Google Scholar 

  4. Bangstad HJ, Osterby R (1994) Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483–490

    Article  CAS  PubMed  Google Scholar 

  5. Mauer SM, Steffes MW, Connett J, Najarian JS, Sutherland DE, Barbosa J et al (1983) The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients. Diabetes 32:948–952

    Article  CAS  PubMed  Google Scholar 

  6. Wilczek HE, Jaremko G, Tydén G, Groth CG et al (1995) Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 59:51–57

    Article  CAS  PubMed  Google Scholar 

  7. Bohman SO, Tydén G, Wilczek H et al (1985) Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34:306–308

    Article  CAS  PubMed  Google Scholar 

  8. Gremizzi C, Vergani A, Secchi A et al (2010) Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15:119–123. doi:10.1097/MOT.0b013e32833552bc

    Article  PubMed  Google Scholar 

  9. Lehmann R, Graziano J, Gerber PA et al (2015) Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up. Diabetes Care. doi:10.2337/dc14-1686

    Google Scholar 

  10. D’Addio F, Vasquez A, Fiorina P et al (2014) Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes 63:3041–3046. doi:10.2337/db14-0295

    Article  PubMed  Google Scholar 

  11. Fiorina P, Vergani A, Sayegh MH et al (2014) Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol 25:1415–1429. doi:10.1681/ASN.2013050518

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. D’Addio F, Trevisani A, Fiorina P et al (2014) Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy. Acta Diabetol 51:897–904. doi:10.1007/s00592-014-0603-1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland

    Matthieu Halfon, Samuel Rotman, Marc Egli, Jean-Pierre Venetz & Manuel Pascual

Authors
  1. Matthieu Halfon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samuel Rotman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc Egli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Pierre Venetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manuel Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Matthieu Halfon or Manuel Pascual.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Ethical standard

All human studies have been reviewed by the appropriate ethics committee.

Human and animal rights disclosure

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent disclosure

Informed consent was obtained from all patients for being included in the study.

Additional information

Managed by Antonio Secchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Halfon, M., Rotman, S., Egli, M. et al. Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy. Acta Diabetol 52, 1175–1177 (2015). https://doi.org/10.1007/s00592-015-0787-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-015-0787-z

Keywords

Search

Navigation